Intimation of Schedule of Analyst/Institutional Investor Meeting
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharma has disclosed the schedule for three upcoming investor meetings in early June 2026: BofA India Conference (June 1), Morgan Stanley India Investment Forum (June 2), and Citi India Conference (June 4). All meetings will be held physically in Mumbai with both group and one-on-one formats. The company has explicitly stated it will not disclose any Unpublished Price Sensitive Information (UPSI) at these meetings. The schedule is subject to change due to exigencies on either side.
This is a routine disclosure indicating normal investor relations activity. No new material information is being shared, and the explicit UPSI clarification is standard compliance practice. Neutral for shareholders.